- Urticaria is a clinical pattern, not a mechanism. It simply means mast-cell–mediated wheals and pruritus, which can arise from:
- IgE cross-linking (true allergy),
- Complement activation (CARPA) releasing C3a, C5a (anaphylatoxins),
- Direct mast-cell degranulation via non-IgE triggers (opioids, contrast, IV iron nanoparticles).
- Urticaria during IV iron infusion ≠ automatically IgE-mediated.
- Most urticarial reactions are non–IgE complement-mediated pseudoallergies (CARPA).1
- True IgE-mediated urticaria/anaphylaxis is exceedingly rare and would require prior sensitization and confirmatory testing.
- True IgE-mediated urticaria would generally:
- Occur after prior exposure to that same formulation,
- Appear rapidly and reproducibly on re-challenge,
- Possibly progress to anaphylaxis if untreated,
- Show positive skin or in vitro testing (rarely done).
- In practice, we treat based on severity, not on presumed mechanism — but understanding this distinction helps avoid overlabeling patients as “iron allergic.”
Oct
11
2025